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ABSTRACT
Zhang, Z., Coyne, D. P., Vidaver, A. K., and Mitra, A. 1998. Expression
of human lactoferrin cDNA confers resistance to Ralstonia solanacearum
in transgenic tobacco plants. Phytopathology 88:730-734.
A construct containing a human lactoferrin cDNA was used to trans-
form tobacco (Nicotiana tabacum) using an Agrobacterium-mediated
DNA-transfer system to express this human protein in transgenic plants.
Transformants were analyzed by Southern, Northern, and Western blots
to determine integration of the cDNA into the plant genome and lactofer-
rin gene expression levels. Most transgenic plants demonstrated signifi-
cant delays of bacterial wilt symptoms when inoculated with the bacterial
pathogen Ralstonia solanacearum. Quantification of the expressed lac-
toferrin protein by enzyme-linked immunosorbent assay in transgenic
plants indicated a significant positive relationship between lactoferrin
gene expression levels and levels of disease resistance. Incorporation of
the lactoferrin gene into crop plants may enhance resistance to other
phytopathogenic bacteria as well.
Additional keywords: antibacterial proteins, Burkholderia, lactoferricin,
Pseudomonas, shiva-1.
Expression of nonplant antibacterial protein genes in engineered
plants has great potential for combating bacterial diseases (12,17,
24). Transgenic potato or tobacco plants have been developed using
constructs encoding shiva-1 (14), SB37 (10,19), or T4 lysozyme
(7) for enhancing resistance of these plants to either bacterial wilt
caused by Ralstonia solanacearum or to soft rot incited by Er-
winia carotovora pv. atroseptica. Both shiva-1 and SB37 are well-
characterized bactericidal peptides (about 4 kDa) that are syn-
thetic derivatives of cecropin found in insect guts (6,12–14). T4
lysozyme, on the other hand, is an antibacterial bacteriophage pro-
tein (7) that disrupts the bacterial membrane (17).
Among numerous nonplant antibacterial proteins isolated to
date, mammalian lactoferrin (Lf), an iron-binding glycoprotein, is
of special interest to us. This protein has long been reported as a
major component of infant defense systems. Its mode of action against
bacteria is more bactericidal than bacteriostatic (5,15). A study on
human and bovine Lf (both sharing a high degree of identity in
their amino acid sequences) revealed that a potent bactericidal do-
main exists in a short peptide sequence termed lactoferricin near
the N-terminal region of the Lf molecule (2). While Lf by itself is
at most bacteriostatic, its N-terminal peptide (about 25 to 47 amino
acids), which can be released by proteolytic cleavage, is highly bac-
tericidal (23). This peptide, lactoferricin, is the shortest active amino
acid sequence that is resistant to further enzymatic cleavage (2).
Another prominent property of Lf or lactoferricin is its potent activ-
ity against a wide range of microorganisms including both gram-
negative and gram-positive bacteria, as well as fungi and viruses.
Lethal concentrations of bovine lactoferricin, for instance, ranged
from 3 to 150 µg/ml against bacteria (1), 18 to 150 µg/ml against
yeast (3,21), and 3 to 60 µg/ml against filamentous fungi (4). Inhi-
bition of a human herpes virus by human and bovine Lf occurs at
concentrations ranging from 0.5 to 1 mg/ml (9). Our previous re-
search (18) demonstrated high levels of in vitro inhibition of several
phytopathogenic bacteria using extracts from Lf-transformed tobacco
calli. These reports suggest that the human Lf gene, once expressed
in plants, may enhance plant resistance to some bacterial pathogens.
Since the tobacco calli used previously (18) were nonregenerable,
the current work was then undertaken to genetically engineer tobacco
with this gene and determine the degree of resistance of transgenic
plants to R. solanacearum. An in vitro assay was further con-
ducted using synthetic bovine lactoferricin and shiva-1 to compare
their antibacterial activity.
MATERIALS AND METHODS
Binary vectors and Agrobacterium strain. Plasmids employ-
ing an Agrobacterium Ti-plasmid binary vector system that con-
tained the human Lf gene (hlf) (pAM1400/hlf) were constructed as
previously described (18), except that the neomycin phosphotrans-
ferase II selectable marker was retained (Fig. 1). The vector plas-
mid pAM1400 without an insert was used as a negative control. A.
tumefaciens strain LBA 4404 was then transformed with either of
these two plasmids as before (18).
Plant material and transformation. Leaf disks of Nicotiana
tabacum cv. Xanthi nc were transformed as described earlier (11).
Kanamycin-resistant primary transformed plants (designated as
T0) were obtained as reported previously (24). Stable integration
of the Lf gene in the genomes of T0 tobacco plants was confirmed
by Southern blots (20) using an hlf cDNA fragment as a probe.
Kanamycin-resistant, hlf-cDNA–containing T0 plants were self-
fertilized to obtain T1 plants.
Analysis of Lf gene expression. Young seedlings of T0 progeny
were screened on modified Murashige and Skoog medium (24)
containing 200 µg of kanamycin per ml, and only kanamycin-re-
sistant seedlings were later challenged with R. solanacearum. For
Northern blots, frozen leaf samples were ground in liquid nitrogen,
and total RNA was extracted using Trizol reagent (Life Technol-
ogies, Inc., Gaithersburg, MD) following the manufacturer’s instruc-
tions. Twenty micrograms of total RNA from each sample was elec-
trophoresed on 1% agarose gels in 1× Tris-borate-EDTA buffer
(20). The gel was then soaked in 7% formaldehyde and 2× SSPE
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(1× SSPE is 0.18 M NaCl, 10 mM NaPO4, and 1 mM EDTA [pH
7.7]) (20) for 15 min each. RNA was blotted onto Zeta-Probe
membranes (BioRad Laboratories, Richmond, CA) in 20× SSPE
transfer buffer overnight by capillary transfer. Both prehybrid-
ization and hybridization were performed at 65°C in the same solu-
tion containing 1 mM EDTA, 0.5 M Na2HPO4, and 7% sodium
dodecyl sulfate (SDS), for 30 min and 16 h, respectively. The mem-
brane was washed for 30 min using a washing solution (1 mM EDTA,
40 mM NaHPO4, and 5% SDS) twice at 65°C and further washed
using another washing solution (1 mM EDTA, 40 mM NaHPO4,
and 1% SDS). The Lf probe was generated by excising a hlf-con-
taining HindIII fragment from the original plasmid and labeling it
with a 32P random labeling system (Gibco BRL; Gaithersburg, MD).
Western blots (BioRad Laboratories) and enzyme-linked immuno-
sorbent assay (ELISA) (BioRad Laboratories) were conducted fol-
lowing manufacturer’s instructions. Rabbit polyclonal antisera (Sigma
Chemical Co., St. Louis) generated using human LF protein was
used as the primary antibody. For sampling, two young, healthy,
and fully expanded leaves from the upper portion of each plant
were collected and stored frozen. These frozen leaf samples were
from T1 transgenic controls (transformed with vector alone) and
from different T1 Lf transformants representing different resistance
responses to R. solanacearum. These T1 transgenic plants were
the progeny of respective primary (T0) transgenic plant lines.
Culturing, storage of R. solanacearum, and in planta tests.
R. solanacearum strain NC251 was provided by T. Denny, De-
partment of Plant Pathology, University of Georgia. R. solana-
cearum was maintained in 80% glycerol at –20°C. To prepare R.
solanacearum inoculum, 50 µl of glycerol suspension was evenly
spread on nutrient broth yeast (NBY) (22) solid medium and
grown at 28°C until separate colonies formed. A single colony
was inoculated into tryptic soy broth (Difco Laboratories, Detroit)
liquid medium and allowed to grow overnight at 28°C with shak-
ing at 200 rpm. The cell suspension, when grown to exponential
phase (A650 = 1), was serially diluted in 12.5 mM phosphate buffer
and cooled on ice for at least 10 min before use. The culturing of
bacteria and all steps of in vivo tests followed previously de-
scribed procedures (16). When transformed plants developed 7 to
10 leaves, they were inoculated with R. solanacearum.
For in planta tests, 5 µl of two different inocula (4.8 × 104 CFU
and 4.8 × 106 CFU) of the R. solanacearum strain were manually
stabbed into the vascular system from a nodal region of the secon-
dary leaf of the bottom stem (16) using a calibrated #20 sewing
needle. In vivo resistance or susceptibility was recorded as the
number of days needed for all the leaves to become totally wilted.
Disease progress was recorded at 3-day intervals. Besides inocu-
lated transgenic vector-only controls and Lf transgenic plants,
additional wild-type plants were inoculated with only 12.5 mM
phosphate buffer. The plants were grown under a 16-h photope-
riod at an average temperature of 28 ± 2°C in growth chambers.
Reisolation of bacteria from inoculated plants. The populations
of bacteria in infected tissues of both the most resistant transformants
and susceptible controls were determined at the time when wilted
control plants began to die. The reisolation was conducted as fol-
lows: 60 mg of a basal portion of the leaf petiole of a fully expanded
young leaf from the top of each inoculated plant was ground
separately in 2 ml of 12.5 mM phosphate buffer using a mortar and
pestle. The bacterial populations were determined as CFU on NBY
plates (22), based on three replicate plate counts for each dilution.
Synthesis of bovine lactoferricin and shiva-1 and assay of
their antibacterial activity. The bovine lactoferricin containing the
antibacterial domain (25 amino acids) and shiva-1 (45 amino acids)
were synthesized following essentially the method reported else-
where (13) through the Protein Core Facility Center at the Univer-
sity of Nebraska-Lincoln. The resultant high-performance liquid
chromatography profiles showed a purity of more than 98%. The
synthesized peptides were lyophilized and stored at –20°C before
use. The in vitro antibacterial activity of these two peptides was deter-
mined by the method described earlier (18). All three bacterial strains
were grown to A600 of 0.4 in NBY liquid medium (22), and 2-ml
aliquots were transferred to culture tubes. Various amounts of syn-
thetic peptides were added to the culture tubes to obtain final concen-
t ations of 0, 1, 10, and 100 µM. Ten microliters of bacterial suspen-
sion at different dilution series was spotted onto the NBY plate. Viable
cell counts were then made on NBY agar as described earlier (18).
RESULTS
Reactions of transgenic tobacco plants to R. solanacearum.
Primary tobacco (N. tabacum cv. Xanthi nc) transformants (T0) were
transformed with a cDNA encoding human Lf (Fig. 1). Individual
transformants were evaluated for bacterial resistance under growth
chamber conditions by manually inoculating them with R. solana-
cearum at two inoculum levels (Table 1). A total of 12 T0 trans-
formed plants including eight Lf transgenic and four transgenic
control plants (transformed with vector alone) as well as three N.
tabacum cv. Xanthi nc 1 (XNC-1) wild-type plants were tested.
The first symptoms of wilt were observed in inoculated control plants
1 week after inoculation. R. solanacearum-inoculated T0 transgenic
tobacco plants expressing Lf protein were significantly delayed in
wilting of both the first leaf and 100% of leaves compared with
either transgenic vector-only controls (XNC-T0-1 and XNC-T0-2)
or nontransgenic wild type (XNC-1) (Table 1). Plants started to
show wilting from the very bottom leaf; hence, 100% leaf wilting
Fig. 1. Schematic diagram of the T-DNA region from the binary vector
pAM1400/hlf. RB and LB, T-DNA right and left border sequences, respec-
tively; Pnos and Tnos, nopaline synthase gene promoter and terminator, re-
spectively; npt II, neomycin phosphotransferase II conferring kanamycin
resistance; P35S, cauliflower mosaic virus 35S promoter; hlf, human lactofer-
rin cDNA; and Probe, segment of DNA used to hybridize blots in Figure 3.
TABLE 1. Responses of T0 human lactoferrin gene (hlf) transgenic tobacco
plants inoculated with Ralstonia solanacearum (9.5 × 106 and 9.5 × 108 CFU/ml)
Inoculum Tobacco line 100% leaf wilt DAIa Delayed wilt (days)b
9.5 × 106 XNC-1 23 0
XNC-T0-1 23 0
XNC-T0-2 22 0
XNC/hlf-T0-1 54 31
XNC/hlf-T0-2 44 21
XNC/hlf-T0-3 54 31
XNC/hlf-T0-4 29 6
9.5 × 108 XNC-1 12 0
XNC-T0-3 11 0
XNC-T0-4 12 0
XNC/hlf-T0-5 29 17
XNC/hlf-T0-6 23 11
XNC/hlf-T0-7 23 11
XNC/hlf-T0-8 44 32
Buffer only XNC-1 NAc NA
a Days after inoculation.
b Delayed wilt is relative to transgenic control plants that wilted 23 days and
12 days after inoculation with 9.5 × 106 and 9.5 × 108, respectively. Delay of
wilting was determined as the number of days needed for the transgenic
plants to show 100% wilt in all the leaves compared with control plants.
Disease progress was recorded at 3-day intervals. The average number of
days in delayed wilting shown by lactoferrin T0 transgenic lines were sig-
nificantly different from those of control lines across two inoculum levels
(P ≤ 0.05) as determined by protected least significant difference.
c NA = not applicable because plants inoculated with buffer did not wilt.
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meant all the leaves were wilted. Although partial wilting in a single
leaf was observed, a leaf was scored as a wilted leaf only when
the whole leaf became wilted in order to make unbiased scoring.
About 3 weeks after inoculation with the 9.5 × 106-CFU/ml inocu-
lum, all the leaves of the control plants wilted, and then they died
1 week later. At a higher inoculum (9.5 × 108 CFU/ml) concentra-
tion, all the leaves of the control plants wilted within 11 to 12 days
after inoculation. In contrast, wilting was delayed in Lf transgenic
plants from 6 days (XNC/hlf-T0-4) to 32 days (XNC/hlf-T0-8) com-
pared with controls, even at the higher inoculum concentration.
Transgenic plants with a delay in wilting of more than 21 days
eventually flowered and produced mature seeds. The plants with
the higher resistance levels produced normal seeds similar to those
of wild-type control plants inoculated only with buffer. However,
micropropagation of seedling nodes had to be used in order to
rescue the Lf transgenic lines (XNC/hlf-T0-2, -4, -5, -6, and -7) and
transgenic control plants that showed early wilting. To confirm the
disease reaction levels and characterize the transgenic plants further,
seeds from these rescued T0 plants were planted, and young seed-
lings were screened on kanamycin-selection growth medium. T1
kanamycin-resistant seedlings (Table 2), representing four different
T0 lines, were selected. A total of 48 T1 plants were then chal-
lenged with the 2.5 × 106-CFU/ml inoculum. About 14 days after
inoculation, all leaves of the control plants were wilted, whereas
wilting of most Lf transgenic plants was significantly delayed
(Fig. 2). However, two progenies of line XNC/hlf-T1-4 did not show
any resistance compared with the controls (Table 2). The maxi-
mum delay in wilting (3 weeks) was observed for transgenic lines
XNC/hlf-T1-2 and XNC/hlf-T1-8 (Table 2 and Fig. 2). Most of the
T1 plants exhibiting a 2-week delay in wilting grew to maturity and
produced seeds; however, a few plants with a 15- to 21-day delay
in wilting did not produce fully mature seeds. Plants with a delay
in wilting of more than 21 days always produced normal seeds.
Analysis of Lf gene expression. RNA extracted from transfor-
mants representing different resistance levels (0, 3, 6, 9, 15, and
21 days of delayed wilting) was analyzed by Northern blotting
(Fig. 3). Transcripts of about 2.3 kb, which corresponded to the
expected full-length Lf mRNA, were detected in all transgenic
plants with various resistance levels to R. solanacearum, except
for controls. Western blot results (Fig. 4) demonstrated differences
in Lf translational levels as indicated by different intensities of Lf
protein bands. The size of these bands (about 80 kDa) corre-
sponded to full-length human lactoferrin protein (HLF). A low-
molecular-weight protein band (48 kDa) was also seen in plants
with high levels of resistance, especially in line XNC/hlf-T1-8, in
addition to the full-length Lf bands (Fig. 4). This 48-kDa band,
previously detected in hlf transgenic calli (18), was only seen in
line XNC/hlf-T1-8, which had the highest bacterial disease resis-
tance level. It appears that a small portion of Lf protein was
truncated or degraded within this transformant. Further quantifica-
tion of total Lf proteins by ELISA assay (Fig. 5) revealed a
positive correlation (+0.964) of enhanced disease resistance with
Lf levels. The estimated HLF protein concentrations ranged from
0.1 to 0.8% of total soluble proteins, depending on the HLF
expression levels in different plants as determined by ELISA.
Reisolation of R. solanacearum from resistant and suscep-
tible plants. To establish the relationship of disease severity with
various levels of R. solanacearum inoculum, R. solanacearum
was isolated from both resistant and vector-only transgenic control
plants when the wilted wild-type control plants started to die. Viable
cells counts (data not shown) could not detect R. solanacearum in
the highly resistant XNC/hlf-T1-8 transgenic plants even at high
Fig. 2. Representative picture of phenotypic symptoms observed in three
different tobacco lines 12 days after inoculation. Left, lactoferrin transgenic
tobacco line (XNC/hlf-T1-8) showing a significant delay in wilting; middle rear,
transgenic control (vector only) tobacco line (XNC-T1-2) showing severe wilt
symptoms and stunted growth; and right, wild-type tobacco line (XNC-1) that
was inoculated with only buffer solution, showing no wilt symptoms.
TABLE 2. Responses of T1 human lactoferrin gene (hlf) transgenic tobacco
plants inoculated with Ralstonia solanacearum (2.5 × 106 CFU/ml inoculum)a
Total number Delayed wilt (days)
c
Plant lineb of plants 0 3 6 9 15 21
XNC-1-1* 1 NAd
XNC-T1-1** 6 6
XNC-T1-3** 6 6
XNC/hlf-T1-2*** 12 6 4 2
XNC/hlf-T1-4*** 12 2 2 6 2
XNC/hlf-T1-5*** 12 2 2 2 6
XNC/hlf-T1-8*** 12 2 4 6
a Data represent the number of plants that have a given delay
b The plant lines were derived from the seeds of corresponding T0 lines.
c Delayed wilting of over 3 days is significantly different (P ≤ 0.05) from con-
trols as detected by protected least significant difference. Delay of wilting was
determined as the number of days needed for the transgenic plants to show
100% wilt in all the leaves compared with control plants. Disease progress was
recorded at 3-day intervals. *, wild-type control plant; **, transgenic vector-
only control plants; and ***, transgenic plants containing the lactoferrin gene.
d NA = not applicable because plants inoculated with buffer did not wilt.
Fig. 3. Northern blot analysis of the tobacco plants representing different resis-
tance levels. Ctrl, mRNA from transgenic control; lanes A, C, and E, mRNA from
lactoferrin transgenic plants (XNC/hlf-T1-5, XNC/hlf-T1-4, and XNC/hlf-T1-8,
respectively) in which wilting was delayed 9, 15, and 21 days, respectively;
lanes B, D, and F, mRNA from lactoferrin transgenic plants (XNC/hlf-T1-4*,
XNC/hlf-T1-5*, and XNC/hlf-T1-2, respectively) in which wilting was delayed
0, 3, and 6 days, respectively; and HLF, lactoferrin mRNA. The bands in the
bottom panel show 18s transcripts as an internal control. The numbers at left
are size markers in kb. * = Different progeny from the same T0 lines.
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inoculum levels and the lowest dilution (<300 CFU/g), while ap-
proximately 8.3 × 108 CFU/g was obtained from the susceptible
controls at 2 weeks after inoculation.
Assay of antibacterial activity of bovine lactoferricin and
shiva-1. A previous study demonstrated enhanced bacterial disease
resistance to R. solanacearum in transgenic potato and tobacco
plants expressing shiva-1 (12,14). Therefore, we further wanted to
determine if the bovine lactoferricin, as both a key antibacterial
component of Lf and a representative of lactoferricin, was more
bactericidal than shiva-1 against phytopathogenic bacteria. We syn-
thesized both bovine lactoferricin and shiva-1 ccording to their pub-
lished sequences (2,6). Three gram-negative pathogens of crop
plants were selected for the experiment: Xanthomonas campestris
pv. phaseoli (common blight of common beans), R. solanacearum
(bacterial wilt), and Pseudomonas syringae pv. phaseolicola (bean
halo blight). These bacteria represent major phytopathogens of either
common beans (Phaseolus vulgaris) or other crop species. At con-
centrations of 10 µM or above, lactoferricin showed more bacteri-
cidal activity in vitro than did shiva-1 against all three bacterial
strains (Table 3) as indicated by a decreased number of CFU. In
particular, strain R. solanacearum was more sensitive to lactofer-
ricin than to shiva-1. At the 100-µM peptide concentration, b vine
lactoferricin completely inhibited colony formation of three bacterial
species at the lowest dilution (10–2) series (≤100 CFU was designated
in this dilution series when no colonies were found) (Table 3).
DISCUSSION
Transferring a human Lf cDNA into tobacco genome enhanced
bacterial disease resistance. Previous results indicated that Lf was
expressed in transgenic calli, and the extracted Lf in total protein
preparations inhibited bacterial multiplication of four bacterial
pathogens in vitro (18). Our current results indicate that inhibition
of bacterial growth leading to increased resistance occurs in planta
as well. These results are encouraging, because wilting was de-
layed over 3 weeks in most resistant transgenic plant lines. There
are no previous reports on the use of the Lf gene to confer resis-
tance to plant pathogens.
It is interesting that intact full-length instead of truncated Lf is
the major protein product (about 80 kDa molecular weight) in
transgenic tobacco plants, in contrast with our earlier findings (18)
that consistently showed major Lf-derived bands at 48 kDa in all
transgenic tobacco calli. Post-translational processing in transgenic
plants may differ from that in transgenic calli. Cells in the callus
stage, especially after undergoing several passages under tissue cul-
ture conditions, undergo different physiological changes and are
known to produce reduced or modified proteins. The effectiveness
of both truncated HLF in our in vitro tests (18) and the full-length
HLF expressed here in in planta tests suggested that their mechan-
isms against bacteria may be correlated. In transgenic plants, how-
ever, it is not clear how Lf affects R. solanacearum in planta. Per-
haps, the full-length HLF may first act as an iron-chelating agent
that reduces the biological availability of iron for the invading
bacteria, causing decreased multiplication of the bacterial popula-
tion. It is also likely that lactoferricin could be released from the
full-length HLF molecule by plant proteases and become bacteri-
cidal, because smaller-sized proteins cross-reacting with HLF anti-
serum were detected in plants with high expression levels of HLF
by using Western blots (Fig. 4). This postulation is deduced from
the fact that the full-length Lf was at most bacteriostatic, whereas
lactoferricin was bactericidal (2). We further speculate that this
truncated, 48-kDa protein could contain the lactoferricin active do-
main, although more molecular evidence confirming this hypothesis
Fig. 4. Western blot analysis of the tobacco plants representing different
resistance levels. Ctrl, transgenic (vector only) control; lanes A, C, and E,
lactoferrin transgenic plants (XNC/hlf-T1-5, XNC/hlf-T1-4, and XNC/hlf-T1-
8, respectively) in which wilting was delayed 9, 15, and 21 days, re-
spectively; lanes B, D, and F, lactoferrin transgenic plants (XNC/hlf-T1-4*,
XNC/hlf-T1-5*, and XNC/hlf-T1-2, respectively) in which wilting was
delayed 0, 3, and 6 days, respectively; and HLF, intact human lactoferrin
protein. The numbers at left are protein standard markers in kDa. * = Dif-
ferent progeny from the same T0 lines.
TABLE 3. Antibacterial activity of synthetic shiva-1 and bovine lactoferricin
peptides against three phytopathogenic bacteria
µM Peptide log10 CFU/ml
a
Bacterial species concentration shiva-1 BLFcnb
Xanthomonas campestris pv. phaseoli 0 9.68 ± 0.08 9.51 ± 0.35
1 9.65 ± 0.11 9.20 ± 0.23
10 9.47 ± 0.07 8.84 ± 0.14
100 2.33 ± 0.58 ≤2.00 ± 0.00
Ralstonia solanacearum 0 9.55 ± 0.18 9.55 ± 0.10
1 9.42 ± 0.09 6.74 ± 0.06
10 9.31 ± 0.12 4.00 ± 0.00
100 8.77 ± 0.02 ≤2.00 ± 0.00
Pseudomonas syringae pv. phaseolicola 0 9.32 ± 0.10 9.62 ± 0.02
1 9.29 ± 0.20 8.59 ± 0.08
10 8.92 ± 0.38 3.13 ± 0.15
100 5.44 ± 0.02 ≤2.00 ± 0.00
a Means are from two independent experiments, each of which contained
three replications. A lower limit of 100 CFU/ml (log10 CFU/ml ≤ 2) was
designated for plate counts when no colony was found at the lowest dilu-
tion series (no dilution). Numbers immediately following the mean indicate
the standard deviation of the mean, i.e., standard deviation of log CFU.
b BLFcn = bovine lactoferricin.
Fig. 5. Relationship between lactoferrin protein levels and different disease resis-
tance responses of transgenic tobacco and control plants. Ctrl, transgenic (vector
only) control; columns A, C, and E, lactoferrin transgenic plants (XNC/hlf-
T1-5, XNC/hlf-T1-4, and XNC/hlf-T1-8, respectively) in which wilting was de-
layed 9, 15, and 21 days, respectively; columns B, D, and F, lactoferrin
transgenic plants (XNC/hlf-T1-4*, XNC/hlf-T1-5*, and XNC/hlf-T1-2, respec-
tively) in which wilting was delayed 0, 3, and 6 days, respectively. Enzyme-
linked immunosorbent assay data were obtained from 10 replications. Bars
represent standard error of a mean. * = Different progeny from the same T0 lines.
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is needed. Degradation of HLF proteins appeared to be less pro-
nounced in our Lf transgenic plants than in transformed calli (18).
Degradation of Lf may, however, be beneficial because of the
release of lactoferricin, which would be more antibacterial.
Variations in resistance levels to R. solanacearum were ob-
served among and within different transgenic plant lines. These may
be due to location of the transgene insertion, different copy numbers,
or homozygosity and heterozygosity of the hlf gene among the T0
progenies. Differential modulation of HLF by Ca2+ and Mg2+,
possibly due to variations in levels of these ions caused by dif-
ferent physiological conditions, may also be responsible for
the nonuniform resistant responses observed in different T1 trans-
genic lines (Fig. 4, lanes B and D, in which Lf levels appear to be
the same based on band intensities in Western blots). This mech-
anism of modulation has been shown previously under in vitro
conditions (1,8). The average height of Lf transformed plants
was about 10% shorter than those of either transgenic or wild-
type controls (data not shown). This effect might be due to the
perturbations and imbalance of iron availability caused by Lf, since
Lf has strong iron-binding ability.
Bovine lactoferricin is a close relative of human lactoferricin (2).
Both peptides are the only antibacterial fragment derived from their
corresponding full-length Lf proteins upon pepsin cleavage, but are
resistant to further pepsin digestion. Furthermore, both peptides
contain an 18-amino acid loop that is critical for their antibacterial
activity (2). However, bovine lactoferricin (25 amino acids and about
3.1 kDa) is more bactericidal than human lactoferricin (47 amino
acids and about 5.6 kDa) (2). Our previous study (18) and data ob-
tained here also strongly suggest that lactoferricin, rather than full-
length Lf, has stronger in planta antibacterial activity in transgenic
plants. Therefore, we chose bovine lactoferricin as a first step to
evaluate its in planta antibacterial potential and compared its activity
with that of shiva-1, one of the most widely reported nonplant bac-
tericidal peptides based on an in vitro assay system. Our data here
clearly showed that bovine lactoferricin was even more potent than
shiva-1 against all three representative phytopathogenic bacteria. In
fact, bovine lactoferricin and shiva-1 are both basic peptides and
serve as membrane-disruptive agents upon interaction with bacterial
membranes (1,2,6,12,14,23,24). However, bovine lactoferricin is
much smaller and more cationic than shiva-1 and contains an 18-
amino acid loop (2). These chemical and structural features may
help lactoferricin penetrate the bacterial membrane more effi-
ciently and protect it from further degradation by plant pro-
teases. This may, in part, explain why lactoferricin showed a
more potent effect than shiva-1 in our assay. These collective re-
sults suggest that lactoferricin, once properly translated but
not severely degraded in engineered plants expressing the lac-
toferricin gene, could confer higher levels of bacterial disease
resistance to transgenic plants than could shiva-1.
The expression of human Lf cDNA conferred resistance to R.
solanacearum in transgenic tobacco plants. It would be useful to
determine if the enhanced bacterial disease resistance may be
achieved by incorporating this mammalian gene or a short syn-
thetic DNA sequence encoding lactoferricin into other economi-
cally important crop plants using plant transformation.
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